# Convalescent Plasma to Limit Coronavirus Associated Complications

> **NCT04325672** · PHASE2 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Coronavirus

## Interventions

- **BIOLOGICAL:** Convalescent Plasma

## Key facts

- **NCT ID:** NCT04325672
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study stopped due to opening Expanded Access Protocol.
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04325672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04325672, "Convalescent Plasma to Limit Coronavirus Associated Complications". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04325672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*